Creatinine, a byproduct of muscle function, may be more sensitive in tracking SMA progression and response to treatment than ...
Patients with spinal muscular atrophy (SMA) type 2 showed improved motor ability when treated with intrathecal onasemnogene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback